Sarah E Baxley

Sarah E Baxley, M.D., Ph.D.

Clinical Assistant Professor

Business Phone: (352) 273-7660
Business Email:

About Sarah E Baxley

Sarah Baxley, MD, PhD, is a clinical assistant professor in the department of obstetrics and gynecology at the University of Florida School of Medicine. She received her PhD and medical degree from the University of Alabama at Birmingham. She then went on to complete a residency in obstetrics and gynecology at the University of Texas and a fellowship in medical education at Yale University. Throughout her career, she has published an array of peer-reviewed articles and presented research at several conferences. Additionally, she is board certified by the American Board of Obstetrics and Gynecology.

As a physician, Dr. Baxley appreciates having long-term relationships with her patients and enjoys treating them and their family members through all stages of life. It is her goal to offer them individualized, comprehensive options for care, including surgery. Patients come to her for treatment of cervical dysplasia, abnormal uterine bleeding, vulvar dysplasia, and vulvar lesions. She also sees patients for general and high-risk obstetrics as well as contraception consultations.

Outside of medicine, Dr. Baxley is a proud mom to her toddler and enjoys quilting, walking, playing tennis and spending time with her family.


APGO CREOG National Faculty Award for Excellence in Resident Education
2022 · Yale University
APGO CREOG National Faculty Award for Excellence in Resident Education
2019 · Yale University
APGO CREOG National Faculty Award for Excellence in Resident Education
2018 · University of Texas Medical Branch

Board Certifications

  • Obstetrics and Gynecology
    American Board of Obstetrics and Gynecology

Clinical Profile

  • Obstetrics and Gynecology
Areas of Interest
  • Abnormal uterine bleeding
  • Birth Control and Family Planning
  • Cervical dysplasia
  • Pregnancy care


Prenatal Discussion of Contraceptive Options in Teenage Pregnancies.
Journal of women's health (2002). 25(5):449-52 [DOI] 10.1089/jwh.2015.5319. [PMID] 26666593.
Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
PloS one. 9(11) [DOI] 10.1371/journal.pone.0113247. [PMID] 25401739.
Misexpression of wingless-related MMTV integration site 5A in mouse mammary gland inhibits the milk ejection response and regulates connexin43 phosphorylation.
Biology of reproduction. 85(5):907-15 [DOI] 10.1095/biolreprod.111.091645. [PMID] 21753195.
Wnt5a as an effector of TGFβ in mammary development and cancer.
Journal of mammary gland biology and neoplasia. 16(2):157-67 [DOI] 10.1007/s10911-011-9205-5. [PMID] 21416313.
Inhibiting breast cancer progression by exploiting TGFbeta signaling.
Current drug targets. 11(9):1089-102 [PMID] 20545612.
Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
Breast cancer research : BCR. 11(2) [DOI] 10.1186/bcr2244. [PMID] 19344510.


Fellowship, Medical Education
2019-2020 · Yale University School of Medicine
Residency, Obstetrics and Gynecology
2012-2016 · University of Texas
Medical School
2005-2012 · University of Alabama at Birmingham
PhD, Cellular and molecular biology
2005-2010 · University of Alabama at Birmingham

Contact Details

(352) 273-7660
Business Street:
PO Box 100294